NCT03740789 Evaluation of Antiviral Indications on Chronic HBV Infection With Different Transaminase Levels Status UNKNOWN Phase N/A
NCT03733652 Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients Status UNKNOWN Phase NA
NCT03714152 A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B Status COMPLETED Phase PHASE1
NCT03672188 Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B Status COMPLETED Phase PHASE1/PHASE2
NCT03662568 A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03642340 A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo Status UNKNOWN Phase N/A
NCT03638076 The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules Status COMPLETED Phase PHASE2
NCT03615066 Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment Status COMPLETED Phase PHASE2
NCT03585322 APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B Status COMPLETED Phase PHASE1
NCT03577171 A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV) Status COMPLETED Phase PHASE2
NCT03576066 A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection Status COMPLETED Phase PHASE2
NCT03575208 Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B Status WITHDRAWN Phase PHASE2
NCT03559790 Treatment Efficacy and Safety of TDF-TAF Switch Study in South Korea Status UNKNOWN Phase N/A
NCT03491553 Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B Status COMPLETED Phase PHASE2
NCT03448744 Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients Status UNKNOWN Phase PHASE4
NCT03439488 A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B Status COMPLETED Phase PHASE1
NCT03434353 Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB) Status TERMINATED Phase PHASE2
NCT03429439 Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B Status UNKNOWN Phase NA